Your Article Summary
See Latest ArticlesDouble allogeneic hematopoietic SCT as a rescue therapy for poor-risk hematological malignancies
Bone Marrow Transplantation, 07/01/09
Stussi G et al. - The authors have shown the feasibility of dHSCT with an acceptable TRM, irrespective of a previous allogeneic HSCT. Whether this approach offers a survival benefit for patients with poor-risk leukemias has to be tested in larger prospective trials.
Related Articles
Drug interactions and adverse events associated with antimycotic drugs used for invasive aspergillosis in hematopoietic SCT
Bone Marrow Transplantation, 12/03/09
Relevance Score: 87%%
Performing allogeneic and autologous hematopoietic SCT in the outpatient setting: effects on infectious complications and early transplant outcomes
Bone Marrow Transplantation, 12/03/09
Relevance Score: 87%%
Parental stress and perceived vulnerability at 5 and 10 years after pediatric SCT
Bone Marrow Transplantation, 11/05/09
Relevance Score: 87%%
Survival of patients with documented autologous recovery after SCT for severe aplastic anemia: a study by the WPSAA of the EBMT
Bone Marrow Transplantation, 11/19/09
Relevance Score: 85%%
Second Allogeneic Stem Cell Transplantation in Myeloid Malignancies
Acta Haematologica, 11/12/09
Relevance Score: 85%%
Today in BMT/SCT...keeping you current
Receive free subspecialty "5-minute updates" via email
Performing allogeneic and autologous hematopoietic SCT in the outpatient setting: effects on infectious complications and early transplant outcomes
Bone Marrow Transplantation, 12/03/09
Dermatologic manifestations of hematopoietic stem cell transplantation: understanding and management
Expert Review of Dermatology, 12/03/09
Comparison of two pretransplant predictive models and a flexible HCT-CI using different cut points to determine low, intermediate and high risk groups: The flexible HCT-CI is the best predictor of NRM and OS in a population of patients undergoing allo-RIC
Biology of Blood and Marrow Transplantation, 12/03/09